The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Endometrial cancer recurrence:  Adjuvant high-dose rate vaginal brachytherapy (HDR) versus HDR with whole pelvic radiation.
Jeannine A Villella
No relevant relationships to disclose
Thomas Palaia
No relevant relationships to disclose
Eva Chalas
No relevant relationships to disclose
Patricia Patrick
No relevant relationships to disclose
Jonathan A. Haas
No relevant relationships to disclose